| 117P Overcoming therapeutic resistance in colorectal cancer by inhibiting neutrophil extracellular traps S Gholami, E Gazzara, J Adrover, A Liu, S Han, Z Aminzada, A Rishi, ... Annals of Oncology 35, S55, 2024 | | 2024 |
| 878 T cell immunotherapies recruit and activate neutrophils to eliminate tumor antigen escape variants D Hirschhorn, S Budhu, L Kraehenbuehl, M Gigoux, D Schröder, A Chow, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 99 T cell immunotherapies trigger neutrophil activation to eliminate tumor antigen escape variants D Hirschhorn, S Budhu, D Schröder, AL Flammar, A Chow, I Schulze, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), A108-A108, 2021 | 1 | 2021 |
| 997 T cell immunotherapies trigger neutrophils to eliminates heterogenous tumors S Budhu, D Redmond, J Ricca, B Gasmi, M Gigoux, C Liu, Y Li, C Cortez, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| 997 T cell immunotherapies trigger neutrophils to eliminates heterogenous tumors S Budha, R Duhen, A Weinberg | | 2022 |
| A bivalent activatable fluorescent probe for screening and intravital imaging of chemotherapyinduced cancer cell death ND Barth, L MendiveTapia, R SubirosFunosas, O Ghashghaei, ... Angewandte Chemie International Edition 61 (5), e202113020, 2022 | 15 | 2022 |
| A delicate interplay between adaptive and innate immunity caused by immunotherapy triggers tumor immunity and aseptic inflammation D Hirschhorn, J Ricca, B Gasmi, O DeHanau, LM Mangarin, S Budhu, Y Li, ... The Journal of Immunology 200 (1_Supplement), 178.42-178.42, 2018 | 6 | 2018 |
| A fluorogenic cyclic peptide for imaging and quantification of drug-induced apoptosis ND Barth, R Subiros-Funosas, L Mendive-Tapia, R Duffin, MA Shields, ... Nature communications 11 (1), 4027, 2020 | 54 | 2020 |
| A framework for advancing our understanding of cancer-associated fibroblasts E Sahai, I Astsaturov, E Cukierman, DG DeNardo, M Egeblad, RM Evans, ... Nature Reviews Cancer 20 (3), 174-186, 2020 | 2651 | 2020 |
| A Potential Synergistic Role of Radiation Therapy with Targeting of the CCL2–CCR2 Signaling Axis in a Murine Model of Breast Cancer P Vempati, L Puckett, C Evans, J Dassler-Plenker, J Curtis, M Egeblad International Journal of Radiation Oncology, Biology, Physics 108 (3), e554-e555, 2020 | 1 | 2020 |
| Abstract A063: cancer cell expression of CCR2 regulates the PD-L1/PD-1 immune checkpoint in breast cancer MR Fein, AS Almeida, A Eberhardt, M Egeblad Cancer Immunology Research 4 (1_Supplement), A063-A063, 2016 | 2 | 2016 |
| Abstract A11: Cancer cell-secreted CXCL1 chemokine acts on neutrophils to support metastasis J Park, J Qiu, ES Nakasone, M Egeblad Cancer Research 73 (3_Supplement), A11-A11, 2013 | | 2013 |
| Abstract A43: Lysyl oxidases are poor therapeutic targets in pancreatic cancer MA Shields, P Maguin, P Kumar, SL Dallas, M Egeblad Cancer Research 75 (13_Supplement), A43-A43, 2015 | | 2015 |
| Abstract B28: Dynamic interplay between type I collagen signaling and invasion in pancreatic cancer MA Shields, P Maguin, SL Dallas, M Egeblad Cancer Research 76 (24_Supplement), B28-B28, 2016 | | 2016 |
| Abstract B42: Targeting cancer cell CCR2 enhances synergistic immune surveillance in breast cancer MR Fein, XY He, AS Almeida, A Pommier, E Bružas, A Eberhardt, ... Cancer Research 78 (10_Supplement), B42-B42, 2018 | | 2018 |
| Abstract B44: Lysyl oxidases suppress pancreatic cancer progression and inhibit FAK and ERK signaling M Shields, P Maguin, C Giuliano, S Dallas, JE Wilkinson, M Egeblad Cancer Research 78 (10_Supplement), B44-B44, 2018 | | 2018 |
| Abstract B62: Modulating innate-adaptive immune cell interactions to achieve tumor rejection AS Almeida, T Kees, M Egeblad Cancer Immunology Research 3 (10_Supplement), B62-B62, 2015 | | 2015 |
| Abstract BS1-2: Neutrophil extracellular traps promote breast cancer metastasis M Egeblad Cancer Research 79 (4_Supplement), BS1-2-BS1-2, 2019 | | 2019 |
| Abstract IA026: Activating a collaborative innate-adaptive immune response to control metastasis M Egeblad Cancer Research 81 (5_Supplement), IA026-IA026, 2021 | | 2021 |
| Abstract IA11: Understanding drug responses and resistance mechanisms using imaging in live mice M Egeblad, E Nakasone, H Askautrud, R Wysocki, M Fein, T Kees, J Park, ... Molecular Cancer Research 12 (11_Supplement), IA11-IA11, 2014 | | 2014 |
Zena WerbProfessor of Anatomy, University of California San Francisco在 ucsf.edu 的电子邮件经过验证
